Weikang Pharmaceuticals

Zhejiang Weikang Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical enterprise dedicated to the modernization and industrialization of Traditional Chinese Medicine (TCM). Founded in 2000 and headquartered in Lishui, Zhejiang, the company operates a vertically integrated business model encompassing medicinal herb cultivation, advanced extraction processes, and large-scale manufacturing of finished drug products. Its diverse portfolio addresses critical therapeutic areas including gastroenterology, cardiovascular health, and respiratory diseases, featuring flagship products such as Yinshuang Granules and Ginkgo Biloba formulations. As a publicly traded company on the Shenzhen Stock Exchange, Weikang leverages scientific innovation and GMP-certified facilities to bridge the gap between traditional herbal remedies and modern clinical standards. The company is recognized as a National High-tech Enterprise and maintains significant R&D collaborations with top-tier academic institutions to drive its product pipeline.